CUSIP: N2451R105
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Total 13F shares
-
5,925,292
-
Share change
-
-13,348,180
-
Total reported value
-
$26,569,978
-
Put/Call ratio
-
60%
-
Price per share
-
$4.52
-
Number of holders
-
56
-
Value change
-
-$73,379,545
-
Number of buys
-
21
-
Number of sells
-
74
Quarterly Holders Quick Answers
What is CUSIP N2451R105?
CUSIP N2451R105 identifies CVAC - CureVac N.V. - Common Shares, par value (euro)0.12 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Previous quarter:
Q3 2025
Recent filing periods for CUSIP N2451R105:
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q4 2025
As of 31 Dec 2025,
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,925,292 shares.
The largest 10 holders included
BlackRock, Inc., ODDO BHF ASSET MANAGEMENT SAS, BANK OF AMERICA CORP /DE/, CSS LLC/IL, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, TWO SIGMA INVESTMENTS, LP, D. E. Shaw & Co., Inc., and Point72 Asset Management, L.P..
This page lists
56
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.